Detalles de la búsqueda
1.
The challenge of hypophosphatasia diagnosis in adults: results from the HPP International Working Group Literature Surveillance.
Osteoporos Int;
35(3): 439-449, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37982856
2.
Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults.
Osteoporos Int;
35(3): 431-438, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37982857
3.
Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents: results from the HPP International Working Group.
Osteoporos Int;
35(1): 1-10, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37982855
4.
Does antenatal cholecalciferol supplementation affect the mode or timing of delivery? Post hoc analyses of the MAVIDOS randomized controlled trial.
J Public Health (Oxf);
45(3): 738-747, 2023 08 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36585903
5.
Short- and long-term prognostic factors associated with functional recovery in elderly patients with hip fracture: A systematic review.
Osteoporos Int;
33(7): 1429-1444, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35247062
6.
European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4-G5D.
Nephrol Dial Transplant;
36(1): 42-59, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33098421
7.
Testing and management for monoclonal gammopathy of uncertain significance and myeloma patients presenting with osteoporosis and fragility fractures.
Rheumatology (Oxford);
58(7): 1142-1153, 2019 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31225884
8.
Correction: Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults.
Osteoporos Int;
35(5): 933-934, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38498158
9.
Dynamic Consent: a potential solution to some of the challenges of modern biomedical research.
BMC Med Ethics;
18(1): 4, 2017 01 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-28122615
10.
Novel use of burosumab in refractory iron-induced FGF23-mediated hypophosphataemic osteomalacia.
Rheumatology (Oxford);
59(8): 2166-2168, 2020 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31930323
11.
Diagnostic journey for individuals with fibrous dysplasia / McCune albright syndrome (FD/MAS).
Orphanet J Rare Dis;
19(1): 50, 2024 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38326833
12.
Patient-reported outcomes measures of X-linked hypophosphataemia participants: findings from a prospective cohort study in the UK.
Orphanet J Rare Dis;
18(1): 26, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36755338
13.
Anticipated effects of burosumab treatment on long-term clinical sequelae in XLH: expert perspectives.
Front Endocrinol (Lausanne);
14: 1211426, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37547321
14.
Patient-reported symptoms and diagnostic journey in Multiple Myeloma.
Front Oncol;
13: 1282569, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38098501
15.
Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials.
BMJ;
381: e068033, 2023 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37130601
16.
Importance of Time Point-Specific Indirect Treatment Comparisons of Osteoporosis Treatments: A Systematic Literature Review and Network Meta-Analyses.
Clin Ther;
44(1): 81-97, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35058055
17.
Musculoskeletal Features in Adults With X-linked Hypophosphatemia: An Analysis of Clinical Trial and Survey Data.
J Clin Endocrinol Metab;
107(3): e1249-e1262, 2022 02 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34636401
18.
Patient-reported experience of clinical care of osteogenesis imperfecta (OI) during the COVID-19 pandemic.
Front Public Health;
10: 951569, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36684962
19.
Overview of fracture liaison services in the UK and Europe: standards, model of care, funding, and challenges.
OTA Int;
5(3 Suppl): e198, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35949498
20.
Prospective Assessment of Tumour Burden and Bone Disease in Plasma Cell Dyscrasias Using DW-MRI and Exploratory Bone Biomarkers.
Cancers (Basel);
15(1)2022 Dec 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36612090